Food Allergies
Home-Based Therapy Achieves 100% Success Rate in Children with High-Threshold Peanut Allergy
February 26, 2025
AAAAI 2025: Phase 2 study results showed POIT with home-measured peanut products was not only highly effective but also posed few risks.
AAAAI 2025: Omalizumab Shows Favorable Outcomes Versus Oral Immunotherapy in Multi‐Food Allergy Treatment
February 12, 2025
In a randomized clinical trial, omalizumab achieved a 36% treatment success rate for multi-food allergy compared with 19% for oral immunotherapy.
Neffy Update: FDA to Review 1 mg Version in First Quarter 2025, for Young Children with Type 1 Allergic Reactions
January 14, 2025
If approved, neffy 1 mg will be the only needle-free epinephrine treatment available for the younger, school-aged population.